The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B

Journal of Gastroenterology

Volumn 45, Issue 12, 2010, Pages 1255-1262

  Fujiwara, Keiichi ^a   Yasui, Shin ^a   Okitsu, Koichiro ^a   Yonemitsu, Yutaka ^a   Oda, Shigeto ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis B; Corticosteroid; Nucleoside analogue; Severe exacerbation

Indexed keywords

BILIRUBIN; CORTICOSTEROID; ENTECAVIR; LAMIVUDINE; METHYLPREDNISOLONE; NUCLEOSIDE ANALOG; PREDNISOLONE; VIRUS DNA;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; NUCLEOSIDES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 78651285740     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0280-y     Document Type: Article

References (25)

1. Editorial. Chemotherapy and hepatitis B. Lancet 1989; ii:1136-7.
2. Y Nakamura T Motokura R Fujita T Yamashita E Ogata 1996 Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies Cancer 78 2210 2215 1:STN:280:DyaK2s%2Fns1SqsQ%3D%3D 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0 8918416 (Pubitemid 26367616)
3. FV Chisari C Ferrari 1995 Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 29 60 1:CAS:528:DyaK2MXltFamtLY%3D 10.1146/annurev.iy.13.040195. 000333 7612225
4. MH Sjogren JH Hoofnagle JG Waggoner 1987 Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis Hepatology 7 582 585 1:STN:280:DyaL2s7pt1Cruw%3D%3D 10.1002/hep.1840070328 3552925 (Pubitemid 17073169)
5. KC Lam CL Lai C Trepo PC Wu 1981 Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis N Engl J Med 304 380 386 1:STN:280:DyaL3M%2FpvVyhug%3D%3D 10.1056/NEJM198102123040702 7005678
6. JH Hoofnagle GL Davis SC Pappas RG Hanson M Peters MI Avigan, et al. 1986 A short course of prednisolone in chronic type B hepatitis Ann Intern Med 104 12 17 1:STN:280:DyaL28%2FnsFequg%3D%3D 3940480
7. GH Scullard CI Smith TC Merigan WS Robinson PB Gregory 1981 Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B Gastroenterology 81 987 991 1:STN:280:DyaL38%2FivVGmsA%3D%3D 7286593
8. JYN Lau GLA Bird AES Gimson GJM Alexander R Williams 1991 Treatment of HBV reactivation after withdrawal of immunosuppression Lancet 337 802 1:STN:280:DyaK3M7ntFOhtg%3D%3D 10.1016/0140-6736(91)91433-U 1672434
9. T Santantonio M Mazzola G Pastore 1999 Lamivudine is safe and effective in fulminant hepatitis B J Hepatol 30 551 553 1:STN:280:DyaK1M3gsFSiug%3D%3D 10.1016/S0168-8278(99)80119-6 10190743 (Pubitemid 29113249)
10. T-M Chan P-C Wu F-K Li C-L Lai IKP Cheng K-N Lai 1998 Treatment of fibrosing cholestatic hepatitis with lamivudine Gastroenterology 115 177 181 1:STN:280:DyaK1czitlGjsQ%3D%3D 10.1016/S0016-5085(98)70380-4 9649474 (Pubitemid 28307303)
11. FT Borg S Smorenburg RA de Man RC Rietbroek RAFM Chamuleau 1998 Recovery from life-threatening corticosteroid-unresponsive chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy Dig Dis Sci 43 2267 2270 10.1023/A:1026622807373 9790464 (Pubitemid 28487257)
12. A Ahmed EB Keeffe 1999 Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection Am J Gastroenterol 94 249 251 1:CAS:528:DyaK1MXhtV2gt7o%3D 10.1111/j.1572-0241.1999.00808.x 9934765 (Pubitemid 29063477)
13. J-P Villeneuve LD Condreay B Willems G Pomier-Layrargues D Fenyves M Bilodeau, et al. 2000 Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B Hepatology 31 207 210 1:CAS:528:DC%2BD3cXks1Ohtg%3D%3D 10.1002/hep.510310130 10613747
14. K Fujiwara O Yokosuka H Kojima T Kanda H Saisho H Hirasawa, et al. 2005 Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B World J Gastroenterol 11 1109 1114 1:CAS:528:DC%2BD2MXjt1ygurw%3D 15754390
15. K Fujiwara S Yasui Y Yonemitsu K Fukai M Arai F Imazeki, et al. 2008 Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B J Gastroenterol 43 711 719 1:CAS:528:DC%2BD1cXhtFCisbvM 10.1007/s00535-008-2222-5 18807133
16. S Iino T Tango T Matsushima G Toda K Miyake K Hino, et al. 2001 Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis Hepatol Res 19 31 40 1:CAS:528: DC%2BD38Xht1yisLw%3D 10.1016/S1386-6346(00)00079-6 11137478 (Pubitemid 32014110)
17. H Okamoto S Okada Y Sugiyama T Tanaka Y Sugai Y Akahane, et al. 1990 Detection of hepatitis C virus RNA by a two-step polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region Jpn J Exp Med 60 215 222 1:STN:280:DyaK3M7lsFahuw%3D%3D 1963453
18. K Fujiwara S Mochida A Matsui N Nakayama S Nagoshi G Toda 2008 Intractable Liver Diseases Study Group of Japan. Fulminant hepatitis and late onset hepatic failure in Japan Hepatol Res 38 646 657 10.1111/j.1872-034X.2008. 00322.x 18328067 (Pubitemid 351784977)
19. JH Hoofnagle 2009 Reactivation of hepatitis B Hepatology 49 S156 S165 1:CAS:528:DC%2BD1MXlvFKqsLk%3D 10.1002/hep.22945 19399803
20. A Tsubota Y Arase Y Suzuki F Suzuki H Sezaki T Hosaka, et al. 2005 Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B J Gastroenterol Hepatol 20 426 432 1:CAS:528:DC%2BD2MXjtlahtLs%3D 10.1111/j.1440-1746.2004.03534.x 15740488 (Pubitemid 40469345)
21. RN Chien CH Lin YF Liaw 2003 The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B J Hepatol 38 322 327 1:CAS:528:DC%2BD3sXhtVemtbk%3D 10.1016/S0168-8278(02)00419-1 12586298 (Pubitemid 36286545)
22. R Tur-Kaspa RD Burk Y Shaul DA Shafritz 1986 Hepatitis B virus DNA contains a glucocorticoid-responsive element Proc Natl Acad Sci USA 83 1627 1631 1:CAS:528:DyaL28XitVWgs7o%3D 10.1073/pnas.83.6.1627 3006059 (Pubitemid 16018617)
23. PB Gregory M Knauer RL Kempson R Miller 1976 Steroid therapy in severe viral hepatitis N Engl J Med 294 681 687 1:STN:280:DyaE287is1Sgsw%3D%3D 10.1056/NEJM197603252941301 765822
24. BG Hansson K Riesbeck E Nordenfelt O Weiland 1991 Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? Prog Clin Biol Res 364 421 427 1:STN:280:DyaK3M3ht1Cguw%3D%3D 1826956
25. K Matsumoto Y Miyake H Miyatake M Takahara T Imada S Yagi, et al. 2009 A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B World J Gastroenterol 15 1650 1652 1:CAS:528:DC%2BD1MXpsFCgs78%3D 10.3748/wjg.15.1650 19340912